Lumicell
MA - NewtonBiotechnology
Focus: Lumicell is a recently founded (2024) biotechnology company specializing in cancer imaging device technology, with a lead product (LUMISIGHT/pegulicianine) approved for intraoperative visualization in oncology. The company is early-stage with minimal disclosed headcount and operates from Newton, MA.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
3+2 this month
Stable — net +2 jobs in 30d
3 added, 1 removed. Backfill posture.
Should You Work at Lumicell?
AI assessmentBest suited for risk-tolerant oncology professionals seeking equity upside and category-building impact, with caveat that undisclosed capitalization and minimal hiring suggest either stealth-mode strategy or early financial stress.
Why Work Here
- Ground-floor opportunity at a newly founded company (2024) with an FDA-approved product (LUMISIGHT) and clear commercial runway through 2034 patent exclusivity
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Help build intelligence for Lumicell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.